U.S. nutrition startup Berry Street said on Monday it has merged with Khosla Ventures-backed Indian startup Healthify to bank on the popular trend of people turning to GLP-1 drugs to lose weight.
The companies didn’t disclose the financial details of the deal. A report from JP Morgan published this year suggested that over 30 million people in the U.S. will be on GLP-1 by 2030.